Clinical Trials in Arizona

Showing 2201-2220 of 16,770 trials

Shared Decision Making to Improve Goals of Care in the ED

NCT03833622

This project will develop and refine a shared decision making (SDM) intervention (decision aid tool) to improve and normalize high quality end of life discussions in the Emergency Department (ED) setting.

Goals

Mayo Clinic230 participantsStarted Mar 2018

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

TERMINATEDPhase 433 miles

An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

NCT05369832

The purpose of this study is to explore the safety, efficacy, effects on quality of life (QOL), and biomarker response of ozanimod in participants with moderate to severely active ulcerative colitis (UC) in clinical practice.

Colitis, Ulcerative

Bristol-Myers Squibb139 participantsStarted Dec 2022

Dothan, Alabama, United States • Chandler, Arizona, United States • Gilbert, Arizona, United States +82 more locations

Shared Decision Making to Improve Goals of Care in the ED

An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Find Trials by Condition in Arizona

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)

A Study of Barzolvolimab in Patients With Atopic Dermatitis

BSGM to Evaluate Patients With GI Symptoms

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

Study of INCB123667 in Subjects With Advanced Solid Tumors

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

FdCyd and THU for Advanced Solid Tumors

EFS of the CardioMech MVRS

Pyrocarbon Clinical Follow-up Study